Search Login Register

Dysplastic Nevus Syndrome (Dysplastic Nevus) Summary

149 relevant articles (3 outcomes, 21 trials/studies) found for this Disease

Description: Clinically atypical nevi (usually exceeding 5 mm in diameter and having variable pigmentation and ill defined borders) with an increased risk for development of non-familial cutaneous malignant melanoma. Biopsies show melanocytic dysplasia. Nevi are clinically and histologically identical to the precursor lesions for melanoma in the B-K mole syndrome. (Stedman, 25th ed)

Also Known As: Dysplastic Nevus; Dysplastic Nevi; Familial Atypical Multiple Mole Melanoma; B K Mole Syndrome; Nevi, Dysplastic Show All >>

Key Drugs and Agents for Dysplastic Nevus Syndrome

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Tretinoin (Retinoic Acid) : 1 outcome 2 studies in 4 results : FDA 25 Generic
  2. Retinoids : 1 outcome in 2 results : IBA
  3. Cyanoacrylates : 1 outcome in 1 result : IBA
  4. DNA (Deoxyribonucleic Acid) : 4 studies in 15 results : IBA
  5. Antigens : 2 studies in 7 results : IBA
  6. Monoclonal Antibodies : 2 studies in 5 results : IBA
  7. Proteins (Proteins, Gene) : 2 studies in 4 results : IBA
  8. nucleolar organizer region associated proteins : 2 studies in 4 results : IBA
  9. Cyclin D1 : 2 studies in 3 results : IBA
  10. Paraffin : 1 study in 16 results : IBA
Show All >>

Diseases Related to Dysplastic Nevus Syndrome

  1. Melanoma (Melanoma, Malignant)
  2. Neoplasms (Cancer)
  3. Skin Diseases
  4. Keratosis
  5. Keratoacanthoma
Show All >>

Key Therapies for Dysplastic Nevus Syndrome

Efficacy Chart >>
  1. Chemoprevention : 4 results
  2. Phototherapy (Light Therapy) : 3 results
  3. Semiconductor Lasers : 1 result
  4. Skin Care : 1 result
  5. Heterologous Transplantation (Xenotransplantation) : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.